Evidence map›Paper›PMID 37265512›Full record

ArticleNuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms2023

Production and separation of positron emitters for hadron therapy at FRS-Cave M.

E Haettner, H Geissel, B Franczak, D Kostyleva, S Purushothaman, Y K Tanaka, F Amjad, D Boscolo, T Dickel, C Graeff and 19 more

Open access · greenAbstract read
In one paragraph

Article in Nuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 4 institutions in 3 countries.

E HaettnerGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
H GeisselGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
B FranczakGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
D KostylevaGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
S PurushothamanGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
Y K TanakaRIKEN Cluster for Pioneering Research, RIKEN, 351-0198, Saitama, Japan.
F AmjadGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
D BoscoloGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
T DickelGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
C GraeffGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
C HesslerGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
C HornungGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
E KazantsevaGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
N KuzminchukGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
D MorrisseyDepartment of Chemistry and NSCL, Michigan State University, 48824, East Lansing, USA.
I MukhaGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
S PietriGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
E RoccoGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
P RoyGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
H RoeschGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
C SchuyGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
P SchüttGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
U WeberGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
H WeickGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
J ZhaoGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
M DuranteGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
K ParodiFaculty of Physics, Department of Medical Physics, Ludwig-Maximilians-Universität München, 85748, München, Germany.
C ScheidenbergerGSI Helmholtzzentrum für Schwerionenforschung GmbH, 64291, Darmstadt, Germany.
Super-FRS Experiment Collaboration
GSI Helmholtz Centre for Heavy Ion Research · DEDarmstadt University of Applied Sciences · DEMichigan State University · USPioneer (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The FRagment Separator FRS at GSI is a versatile spectrometer and separator for experiments with relativistic in-flight separated short-lived exotic beams. One branch of the FRS is connected to the target hall where the bio-medical cave (Cave M) is located. Recently a joint activity between the experimental groups of the FRS and the biophysics at the GSI and Department of physics at LMU was started to perform biomedical experiments relevant for hadron therapy with positron emitting carbon and oxygen beams. This paper presents the new ion-optical mode and commissioning results of the FRS-Cave M branch where positron emitting

Indexed as

Hadron therapyIn-flight separatorIon opticsPositron emitter

Identifiers

PMID37265512
PMCPMC7614599
OpenAlexW4377090499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.